Stem Cell Therapies for Treatment of Cartilage and Bone Disorders: Osteoarthritis, Avascular Necrosis, and Non-union Fractures

PM and R

Volumn 7, Issue 4, 2015, Pages S26-S32

  Sampson, Steven ^a,d,e   Botto van Bemden, Angie ^b   Aufiero, Danielle ^a,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c Orthohealing Center   (United States)

^d WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^e TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AVASCULAR NECROSIS; BONE MARROW CONCENTRATE THERAPY; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW TRANSPLANTATION; CARTILAGE DEGENERATION; FRACTURE NONUNION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; CYTOLOGY; FRACTURES, UNUNITED; MESENCHYMAL STROMA CELL; PROCEDURES;

FRACTURES, UNUNITED; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OSTEOARTHRITIS;

EID: 84940777401     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2015.01.023     Document Type: Article

References (51)

1. Kraus V.B., Feng S., Wang S., et al. Subchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression. Arthritis Rheum 2013, 65:1812-1821.
2. Gupta P.K., Das A.K., Chullikana A., Majumdar A.S. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther 2012, 3:25.
3. Frazer A., Bunning R., Thavarajah M., et al. Studies on type II collagen and aggrecan production in human articular chondrocytes in vitro and effects of transforming growth factor-β and interleukin-1 β. Osteoarthritis Cartilage 1994, 2:235-245.
4. Goldring M.B. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000, 43:1916-1926.
5. Centeno C.J., Schultz J.R., Cheever M., et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 2011, 6:368-378.
6. Steinert A.F., Rackwitz L., Gilbert F., Noth U., Tuan R.S. Concise review: The clinical application of mesenchymal stem cells for musculoskeletal regeneration: Current status and perspectives. Stem Cells Transl Med 2012, 1:237-247.
7. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
8. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998, 4:415-428.
9. Caplan A. MSCs: The New Medicine. Regenerative Medicine. Presented at the Annual Meeting of The Orthobiologic Institute (TOBI). June 2014, Los Angeles, CA.
10. Lewandowski K., Kowalik M.M., Pawlaczyk R., Rogowski J., Hellmann A. Microscopic examination of bone marrow aspirate in healthy adults-comparison of two techniques of slide preparation. Int J Lab Hematol 2012, 34:254-261.
11. Caplan A.I. Review: Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics. Tissue Eng 2005, 11:1198-1211.
12. Noth U., Steinert A.F., Tuan R.S. Technology insight: Adult mesenchymal stem cells for osteoarthritis therapy. Nature Clin Prac Rheumatol 2008, 4:371-380.
13. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213:341-347.
14. Hernigou P., Zilber S., Filippini P., Rouard H., Methieu G., Poignard A. Bone marrow injection in hip osteonecrosis. Tech Orthop 2008, 23:18-25.
15. Jorgensen C., Noel D. Mesenchymal stem cells in osteoarticular diseases. Regen Med 2011, 6(6 Suppl):44-51.
16. Dar A., Goichberg P., Shinder V., et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005, 6:1038-1046.
17. Wynn R.F., Hart C.A., Corradi-Perini C., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
18. Davatchi F., Abdollahi B.S., Mohyeddin M., Shahram F., Nikbin B., et al. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 2011, 14:211-215.
19. Schultz JR. Treatment Registry Data on 1,000 Hip and Knee OA patients with Same Day Stem Cell Isolates from Bone Marrow. Presented at the Annual Meeting of The Orthobiologic Institute. June 2014, Los Angeles, CA, unpublished.
20. Emadedin M., Aghdami N., Taghiyar L., et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 2012, 15:422-428.
21. Sampson S. Early Results with Bone Marrow Concentrate & Emerging Trends in Biologics. Presented at the Annual Meeting of The Orthobiologic Institute, June 2014, Los Angeles, CA, unpublished.
22. Sampson S., Botto-van Bemden A., Aufiero D. Autologous bone marrow concentrate: Review and application of a novel intra-articular orthobiologic for cartilage disease. Phys Sport 2013, 41:7-18.
23. Li W., Sakai T., Nishii T., et al. Distribution of TRAP-positive cells and expression of HIF-1alpha, VEGF, and FGF-2 in the reparative reaction in patients with osteonecrosis of the femoral head. J Orthop Res 2009, 27:694-700.
24. Cardozo J.B., Andrade D.M., Santiago M.B. The use of bisphosphonate in the treatment of avascular necrosis: A systematic review. Clin Rheumatol 2008, 27:685-688.
25. Hernigou P., Poignard A., Manicom O., et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 2005, 87:896.
26. Lieberman J.R., Engstrom S.M., Meneghini R.M., SooHoo N.F. Which factors influence preservation of the osteonecrotic femoral head?. Clin Orthop Relat Res 2012, 470:525-534.
27. Alves E.M., Angrisani A.T., Santiago M.B. The use of extracorporeal shock waves in the treatment of osteonecrosis of the femoral head: A systematic review. Clin Rheumatol 2009, 28:1247-1251.
28. Yan Z., Hang D., Guo C., Chen Z. Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res 2009, 27:442-446.
29. Wen Q., Ma L., Chen Y.P., Yang L., Luo W., Wang X.N. Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells. Gene Ther 2008, 15:1523-1535.
30. Annaloro C., Onida F., Lambertenghi Deliliers G. Autologous hematopoietic stem cell transplantation in autoimmune diseases. Expert Rev Hematol 2009, 2:699-715.
31. Rosato E., Pisarri S., Salsano F. Current strategies for the treatment of autoimmune diseases. J Biol Regul Homeost Agents 2010, 24:251-259.
32. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010, 67:1187-1194.
33. Szodoray P., Varoczy L., Szegedi G., Zeher M. Autologous stem cell transplantation in autoimmune and rheumatic diseases: From the molecular background to clinical applications. Scand J Rheumatol 2010, 39:1-11.
34. Mazo M., Planat-Bénard V., Abizanda G., et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur J Heart Fail 2008, 10:454-462.
35. Mazo M., Gavira J.J., Abizanda G., et al. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant 2010, 19:313-328.
36. Mark A.L., Sun Z., Warren D.S., et al. Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg 2010, 252:591-596.
37. Walker P.A., Shah S.K., Jimenez F., et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol 2010, 225:341-352.
38. Walczak P., Zhang J., Gilad A.A., et al. Dual modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574.
39. Hendrich C., Franz F., Waertel G., et al. Safety of autologous bone marrow aspiration concentrate transplantation: Initial experiences in 101 patients. Orthop Rev 2009, 1:e32.
40. Yoshioka T., Mishima H., Akaogi H., et al. Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop 2011, 35:823-829.
41. Kumar Sen R., Kumar Tripathy S., Aggarwal S., et al. Results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis. J Arthroplasty 2012, 27:679-686.
42. Wang B.L., Sun W., Shi Z.C., et al. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 2010, 130:859-865.
43. Samir Kassem M. Percutaneous autogenous bone marrow injection for delayed union or non union of fractures after internal fixation. Acta Orthop Belg 2013, 79:711-717.
44. Padha V., Mahajan N., Kalsotra N. Role of percutaneous bone marrow injection in delayed union and non union. Internet J Orthoped Surgery 2011, 18.
45. Braly H.L., O'Connor D.P., Brinker M.R. Percutaneous autologous bone marrow injection in the treatment of distal meta-diaphyseal tibial nonunions and delayed unions. J Orthop Trauma 2013, 27:527-534.
46. Hernigou P., Poignard A., Beaujean F., et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005, 87:1430-1437.
47. Connolly J.F., Guse R., Tiedeman J., et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991, 266:259-270.
48. Garg N.K., Gaur S., Sharma S. Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 1993, 64:671-672.
49. Goel A., Sangwan S.S., Siwach R.C., et al. Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 2005, 36:203-206.
50. Healey J.H., Zimmerman P.A., McDonnell J.M., et al. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 1990, 256:280-285.
51. Watson J. Autologous stem cell research and clinical use: Evolving concepts of how cells communicate. Presented at The Orthobiologic Institute (TOBI ) Symposium, 2013, Los Angeles, CA.